Mental Health DailyResearch. Evidence. Perspective.Published research on weight gain.
Rexulti (Brexpiprazole), is an atypical antipsychotic that was jointly developed by pharmaceutical companies Otsuka and Lundbeck. In 2015, the FDA approved Rexulti for the treatment of schiz…
Read articleTrintellix (Vortioxetine hydrobromide), formerly sold under the name Brintellix, is an antidepressant that was jointly developed by the pharmaceutical companies Lundbeck and Takeda. In 2013,…
Read articleRexulti (Brexpiprazole), is an atypical antipsychotic approved by the FDA for the treatment of schizophrenia and major depressive disorder (as an adjunct). The drug was engineered via collab…
Read articleCoffee is a brewed drink prepared from the roasting of coffee beans, which technically, are seeds of berries produced by the Coffea plant. Specifically, when Coffea plant berries ripen, they…
Read articleNiacin (vitamin B3), also referred to as nicotinic acid, is a human nutrient that functions as a precursor to NAD (nicotinamide adenine dinucleotide) and NADP (nicotinamide adenine dinucleot…
Read articleSynthroid (Levothyroxine) is a medication commonly prescribed for the treatment of hypothyroidism, and is also a popular intervention for goiters, nodular thyroid disease, and thyroid cancer…
Read articleHydroxyzine is an antihistaminergic drug that was initially marketed in the 1950s by Pfizer. It is manufactured under the brand names Vistaril and Atarax, but widely purchased as a generic. …
Read article